Rennova Health

We are a vertically integrated public healthcare holding company. We focus on serving essential healthcare categories, especially those with unmet needs and significant opportunities for innovation-driven solutions. We develop and operate forward-thinking businesses, systems and services to support better treatment outcomes, more cost-effective patient care, and optimized revenue streams. We are committed to providing unmatched service excellence across our entire suite of solutions while building on the best medical science and innovative technologies available. We also maintain the highest standards of corporate transparency, fiduciary responsibility, accountability, and regulatory compliance.
Type
Public
HQ
West Palm Beach, US
Size (employees)
185 (est)
Rennova Health is headquartered in West Palm Beach, US

Rennova Health Office Locations

Rennova Health has offices in West Palm Beach, Tustin, Miami, Waldwick and in 1 other location
West Palm Beach, US (HQ)
800 400 S Australian Ave
Las Cruces, US
410 Foster Rd
Waldwick, US
71 Franklin Turnpike
Miami, US
Miami International Business Center 3399 Nw 72nd Ave
Tustin, US
14351 Myford Rd
West Palm Beach, US
7960 Central Industrial Dr

Rennova Health Data and Metrics

Rennova Health Financial Metrics

Rennova Health's revenue was reported to be $5.2 m in FY, 2016
USD

Revenue (FY, 2016)

5.2 m

Revenue growth (FY, 2015 - FY, 2016), %

(71%)

Gross profit (FY, 2016)

3.5 m

Gross profit margin (FY, 2016), %

68%

Net income (FY, 2016)

(32.6 m)

EBIT (FY, 2016)

(32.4 m)

Market capitalization (20-Jul-2017)

2.5 m

Closing share price (20-Jul-2017)

0.4

Cash (31-Dec-2016)

78 k

EV

15.4 m
Rennova Health's current market capitalization is $2.5 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

57.9 m18.4 m5.2 m

Revenue growth, %

(68%)(71%)

Cost of goods sold

15.9 m9.3 m1.7 m

Gross profit

42 m9.1 m3.5 m

Gross profit Margin, %

73%49%68%

Sales and marketing expense

2.5 m

General and administrative expense

23.7 m

Operating expense total

42.3 m63.9 m37.6 m

EBIT

15.7 m(45.5 m)(32.4 m)

EBIT margin, %

27%(247%)(618%)

Interest expense

513.8 k2.7 m6.3 m

Pre tax profit

15.4 m(45 m)(33.3 m)

Income tax expense

(735 k)

Net Income

7.8 m(36 m)(32.6 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

56 k64 k176 k94 k108 k116 k1.9 m3.1 m290 k

Cost of goods sold

104 k18 k18 k18 k26 k26 k

Gross profit

(48 k)46 k158 k76 k82 k90 k

Gross profit Margin, %

(86%)72%90%81%76%78%

Sales and marketing expense

57 k80 k73 k68 k110 k59 k873.4 k590.3 k570.8 k

R&D expense

21 k50 k32 k1 k21 k

General and administrative expense

365 k644 k553 k672 k753 k474 k6 m5.9 m7 m

Operating expense total

443 k774 k658 k741 k884 k533 k6.8 m6.5 m7.6 m

EBIT

(1 m)(1.3 m)(1 m)(1.1 m)(1.4 m)(964 k)(6.8 m)(5.1 m)(12.6 m)

EBIT margin, %

(1823%)(1984%)(590%)(1213%)(1251%)(831%)(360%)(167%)(4337%)

Interest expense

(1 m)(2 m)(1.6 m)

Pre tax profit

(4.2 m)(5.9 m)(12 m)

Income tax expense

(20 k)(13 k)(11 k)

Net Income

(1 m)(1.1 m)(1.3 m)(956 k)(5.9 m)(12 m)
USDFY, 2014FY, 2015FY, 2016

Cash

2.4 m8.8 m78 k

Accounts Receivable

17.5 m8.1 m1.5 m

Current Assets

20.3 m22 m3.2 m

PP&E

7.7 m7.1 m3.1 m

Total Assets

35.8 m29.4 m6.5 m

Accounts Payable

3.4 m4.4 m3.4 m

Total Debt

6.7 m12 m12.9 m

Current Liabilities

18.1 m17.8 m19.6 m

Total Liabilities

20.7 m30.6 m21.4 m

Additional Paid-in Capital

5.2 m26.8 m45.7 m

Retained Earnings

9.6 m(28 m)(60.6 m)

Total Equity

15 m(1.2 m)(14.9 m)

Debt to Equity Ratio

0.4 x-10.1 x-0.9 x

Debt to Assets Ratio

0.2 x0.4 x2 x

Financial Leverage

2.4 x-24.6 x-0.4 x
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2016Q2, 2016Q3, 2016

Cash

2.4 m2.1 m1.1 m193 k4.9 m485.2 k514.3 k

Accounts Receivable

55 k124 k73 k47 k7.1 m7.8 m2.7 m

Current Assets

3.1 m2.8 m1.7 m805 k15.8 m12.4 m4.7 m

PP&E

135 k134 k127 k117 k6.4 m5.8 m5.1 m

Goodwill

603 k603 k603 k603 k

Total Assets

5.2 m4.8 m3.6 m2.7 m22.5 m18.4 m10.2 m

Accounts Payable

276 k156 k175 k3.4 m3.8 m2.6 m

Current Liabilities

361 k633 k569 k610 k18.8 m20.2 m18.4 m

Additional Paid-in Capital

130.9 m132.5 m132.6 m132.7 m26.7 m27 m39.6 m

Retained Earnings

(127.1 m)(129.3 m)(130.4 m)(131.5 m)(32.3 m)(38.1 m)(50.1 m)

Total Equity

3.8 m3.2 m2.3 m1.3 m(5.4 m)(10.9 m)(10 m)

Financial Leverage

1.4 x1.5 x1.6 x2.1 x-4.1 x-1.7 x-1 x
USDFY, 2014FY, 2015FY, 2016

Net Income

7.8 m(36 m)(32.6 m)

Depreciation and Amortization

3 m

Accounts Receivable

3.1 m

Accounts Payable

(905.6 k)

Cash From Operating Activities

7.7 m(12.6 m)(19.9 m)

Purchases of PP&E

(2.5 m)(456.3 k)(36.7 k)

Cash From Investing Activities

(4 m)4.3 m63.3 k

Cash From Financing Activities

(5.4 m)14.7 m11 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(1 m)(1.1 m)(1.3 m)(956 k)(5.9 m)(12 m)

Depreciation and Amortization

727.3 k701.7 k702.3 k

Accounts Receivable

55 k124 k73 k47 k192 k40 k7.1 m7.8 m2.7 m

Accounts Payable

276 k156 k175 k420 k289 k3.4 m3.8 m2.6 m
USDY, 2016

EV/EBIT

-0.5 x

EV/CFO

-0.8 x

Revenue/Employee

28.4 k

Debt/Equity

-0.9 x

Debt/Assets

2 x

Financial Leverage

-0.4 x

Rennova Health Market Value History

Rennova Health Revenue Breakdown

Rennova Health Online and Social Media Presence

Rennova Health Company Life and Culture

You may also be interested in